Financial barriers to the adoption of combination vaccines by pediatricians.

Authors:
Address: Children’s Hospital Boston, Boston, Massachusetts, USA. gidengil@rand.org
Journal:

Publication:

abstract

OBJECTIVES:

To describe the prevalence of combination vaccine use and the associated Financial barriers faced by pediatric practices, and to identify determinants of adoption of combination vaccines.

DESIGN:

Mailed national survey.

SETTING:

Pediatric practices during the period from August through October 2008.

PARTICIPANTS:

pediatricians randomly selected from the American Medical Association Masterfile.

MAIN OUTCOME MEASURE:

Use of 1 of 2 infant combination vaccines (the diphtheria and tetanus toxoids and acellular pertussis, hepatitis B virus, and inactivated poliovirus [DTaP-HepB-IPV] vaccine or the DTaP, IPV, and Haemophilus influenzae type b [DTaP-IPV/Hib] vaccine).

RESULTS:

We received 629 responses (response rate, 67%). Four hundred ninety-two pediatricians (78%) reported using 1 or both of the infant combination vaccines of interest (ie, the DTaP-HepB-IPV or DTaP-IPV/Hib vaccine). More than half of the respondents said their practice did not receive adequate reimbursement for the purchase and administration of vaccines in general. More than one-fifth reported not using 1 or more of the combination vaccines because of inadequate reimbursement for the cost of vaccine doses (23% of respondents) and/or vaccine administration (20% of respondents). The infant combination vaccines studied were less likely to be used by smaller practices, by those with a lower proportion of publicly insured patients, and by those with less inclusive state vaccine financing policies.

CONCLUSIONS:

One in 5 pediatricians reported that inadequate reimbursement prevented their using 1 or more combination vaccines. Practice size as well as the proportion of children whose vaccinations are paid for by public funds appear to be important determinants of the adoption of combination vaccines.

Related Articles
Financial barriers to implementing combination vaccines: perspectives from pediatricians and policy makers.
Clin Pediatr (Phila). 2009
Financial barriers to implementing combination vaccines: perspectives from pediatricians and policy makers.
Gidengil CA, Rusinak D, Allred NJ, Luff D, Lee GM, Lieu TA. Clin Pediatr (Phila). 2009 Jun; 48(5):539-47. Epub 2009 Mar 24.
Use of a new combined vaccine in pediatric practices.
Pediatrics. 2006
Use of a new combined vaccine in pediatric practices.
Freed GL, Cowan AE, Clark SJ, Santoli J, Bradley J. Pediatrics. 2006 Aug; 118(2):e251-7. Epub 2006 Jul 10.
The conundrum of combination vaccines.
Arch Pediatr Adolesc Med. 2010
The conundrum of combination vaccines.
Davis MM. Arch Pediatr Adolesc Med. 2010 Dec; 164(12):1171-2.
Review New combination vaccines: integration into pediatric practice.
Pediatr Infect Dis J. 2007
Review New combination vaccines: integration into pediatric practice.
Pierce VM, Vázquez M. Pediatr Infect Dis J. 2007 Dec; 26(12):1149-50.
Review Immunizations in the United States: a rite of passage.
Pediatr Clin North Am. 2005
Review Immunizations in the United States: a rite of passage.
Cohn AC, Broder KR, Pickering LK. Pediatr Clin North Am. 2005 Jun; 52(3):669-93, v.

To top • Home

TraveldoctorOnline 2001 • Disclaimer • webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.